These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 551896)

  • 21. Neurotransmitter release, vascular responsiveness and their suppression by Ca-antagonist in perfused mesenteric vasculature of DOCA-salt hypertensive rats.
    Tsuda K; Kuchii M; Nishio I; Masuyama Y
    Clin Exp Hypertens A; 1986; 8(2):259-75. PubMed ID: 3720003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The possible mode of action of indapamide: a review.
    Campbell DB
    Curr Med Res Opin; 1983; 8 Suppl 3():9-24. PubMed ID: 6352188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retardation of the development of hypertension in DOCA-salt rats by renal denervation.
    Takahashi H; Iyoda I; Yamasaki H; Takeda K; Okajima H; Sasaki S; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1984 Jun; 48(6):567-74. PubMed ID: 6547490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of delapril combined with indapamide or hydrochlorothiazide in spontaneously hypertensive stroke-prone rats: a comparative dose-response analysis.
    Boschi S; Vantaggiato G; Torri C; Zini I; Agnati LF; Zoli M; Biagini G
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):321-8. PubMed ID: 10975589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs.
    Hamed AT; Lokhandwala MF
    Clin Exp Hypertens A; 1982; 4(6):867-81. PubMed ID: 6284412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An antihypertensive action of propranolol in DOCA/salt-treated rats.
    Dusting GJ; Rand MJ
    Clin Exp Pharmacol Physiol; 1974; 1(1):87-98. PubMed ID: 4457268
    [No Abstract]   [Full Text] [Related]  

  • 28. Correction of altered noradrenaline reactivity in essential hypertension by indapamide.
    Grimm M; Weidmann P; Meier A; Keusch G; Ziegler W; Glück Z; Beretta-Piccoli C
    Br Heart J; 1981 Oct; 46(4):404-9. PubMed ID: 7295437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extrarenal contributions to indapamide's antihypertensive mechanism of action.
    Noveck RJ; McMahon FG; Quiros A; Giles T
    Am Heart J; 1983 Jul; 106(1 Pt 2):221-9. PubMed ID: 6869204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine.
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    J Hypertens; 1989 Dec; 7(12):947-54. PubMed ID: 2576430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of delapril, indapamide and their combination on stroke occurrence and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
    Razzetti R; Bongrani S; Oberto G; Ferrari R; Biagini G
    Arzneimittelforschung; 1998 Nov; 48(11):1083-7. PubMed ID: 9850429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies of antihypertensional mechanism of indapamide (author's transl)].
    Weidmann P; Grimm M; Meier A; Keusch G; Ziegler W; Glück Z; Beretta-Piccoli C
    Schweiz Rundsch Med Prax; 1982 Feb; 71(7):282-8. PubMed ID: 7111213
    [No Abstract]   [Full Text] [Related]  

  • 34. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
    Malherbe E; Le Hegarat M; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of chemical sympathectomy on the development of DOCA-salt hypertension in rats].
    Vakulina TP; Markov KhM; Pinelis VG; Kozlov AV; Mukhammedov A
    Biull Eksp Biol Med; 1983 Dec; 96(12):22-5. PubMed ID: 6661541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of indapamide, a thiazide-like diuretic, on structure of cerebral arterioles in hypertensive rats.
    Chillon JM; Baumbach GL
    Hypertension; 2004 May; 43(5):1092-7. PubMed ID: 15007039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propranolol in DOCA hypertensive rats: development of hypertension inhibited and pressor responsiveness enhanced.
    Buñag RD
    Eur J Pharmacol; 1977 Jun; 43(4):323-31. PubMed ID: 880980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorthalidone reduces vascular hyperresponsiveness in DOCA-salt hypertensive rats.
    Cabral AM; Musso MN; Bissoli NS; Carvalhinho FB; Vasquez EC
    Clin Exp Hypertens A; 1992; 14(4):667-83. PubMed ID: 1628412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL; Delcayre C; Besnard JC; Paolaggi F; Mouas C; Swynghedauw B
    Arch Int Pharmacodyn Ther; 1991; 314():5-24. PubMed ID: 1840461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.